Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe E. who wrote (2469)	10/24/1997 6:42:00 PM
From: BLUE HORSE SHOE	of 6136

The Immune Response Corp., Recently announced that data from a recently completed open-label trial of 15 patients which suggests that Remune induces the production of beta chemokines. This data demonstrates yet another advantage of Remune in protecting the patient from further HIV infection. Remember Remune is designed to be a possible compliment to the current antiviral drugs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next